WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS

DRINKING WATER PRODUCTS

The new Ascentis® Express PFAS HPLC column, with its Fused-Core technology and a particle size of 2.7 μm, delivers fast and high-resolution separations with excellent selectivity, peak shape, and necessary retention to perform in EPA methods 537.1, 533 and 8327.

Containerized seawater desalination solutions ensure water availability in a wide range of applications.

Bio-Microbics introduces a new generation of wastewater treatment solutions, the BioBarrier® HSMBR® (High Strength Membrane Bioreactor), to help meet the increasingly stringent needs of specialized applications. The membranes and processes used in this advanced system act as an impenetrable physical barrier for nearly all common pollutants found in wastewater today. The advanced technology offers the highest quality effluent possible on the market.  The BioBarrier® MBR was the first system to be approved for water reuse (NSF/ANSI Std 350, class R) by the NSF (National Sanitation Foundation) International.

The presence of active pharmaceutical ingredients, radio-opaque substances and endocrine disrupting chemicals in raw water sources is a relatively new emerging issue in relation to drinking water quality. However, the influence of pollutants on health and general well-being is becoming apparent with the incidence of carcinoma increasing and fertility rates being affected. A solution for the efficient removal of these substances from water use by production sites is required.

Based on proven electrodialysis reversal (EDR) technology, the END® system transforms two key components of traditional EDR to deliver maximum recovery with minimum energy consumption in numerous brackish water treatment applications.

The NeoTech D228™ is specially designed to disinfect water and is an essential component in advanced oxidation processes.

VIEWS ON THE LATEST REGS

  • The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
  • Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
  • In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
  • With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
  • A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.

MORE WATER INDUSTRY FEATURES